Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
bristol-myers squibb
cancer
clinical trials
glaxosmithkline
merck
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
third rock ventures
wisconsin blog main
wisconsin top stories
acadia pharmaceuticals
adverum biotechnologies
aimmune
alk
array biopharma
astrazeneca
avalon ventures
aveo oncology
barcelona
beacon
biogen
What
cancer
3
×
drug
medical
advanced
annual
arrival
ash
award
barcelona
bio
clinical
conference
data
death
decades
december's
dems
despite
esmo
european
family
given
hardest
hit
hottest
hunters
immunotherapy
ipo
kras
longer
lung
major
medicines
meeting
oncology
parp
pricing
prostate
proteins
quick
Language
unset
Current search:
roche
×
cancer
×
amgen
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
